Natco Pharma announces rights issue at Rs 750 per share

Fund Raising View source PDF Explain this filing

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹842.20

prior close

₹842.00

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.0%-0.6% vs market

Pharmaceuticals peers, median of 171sector-0.0%-0.6% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Smallcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.3

15m

+0.2

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.0-0.6-0.0-0.6

Next day

-1.7-1.6-0.1-1.3-0.4

+0.0-2.2+2.3-0.6+0.6

-1.9-2.0+0.0-1.6-0.3

-2.8-3.1+0.4-2.5-0.3

-2.4-2.8+0.4-2.7+0.3

-3.7-1.3-2.4-2.2-1.5

15d

-4.7-4.0-0.7-6.1+1.4

-5.8-8.7+2.9-9.3+3.5

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natco Pharma board has approved a rights issue in ratio 2:21 at Rs 750 per share (face value Rs 2, premium Rs 748). Total issue size about Rs 1,279 crore for 1.7 crore shares. Record date October 1, 2026. Issue opens October 12 and closes October 22, 2026.

Likely market impact

Dilution for non-subscribing shareholders. Existing holders get priority to maintain stake at the issue price.